Skip to main content

Table 2 Comorbidity or other characteristics that are risk factors for pneumococcal pneumonia among patients > 50 years old hospitalized for community-acquired pneumonia, after adjustment on age and sex

From: The impact of comorbidities and their stacking on short- and long-term prognosis of patients over 50 with community-acquired pneumonia

Characteristics of the patients

All patients

Age group 50–69 y.o.

Age group 70–89 y.o

Age group ≥ 90 y.o.

 

OR [95% CI]

p value

OR [95% CI]

p value

OR [95% CI]

p value

OR [95% CI]

p value

Alcohol abuse

1.48 [1.38;1.58]

 < 0.0001

1.64 [1.50;1.78]

 < 0.0001

1.25 [1.11;1.41]

0.0002

1.39 [0.87;2.23]

0.163

Tobacco abuse

1.83 [1.73;1.94]

 < 0.0001

1.79 [1.66;1.93]

 < 0.0001

1.88 [1.72;2.06]

 < 0.0001

2.21 [1.58;3.10]

 < 0.0001

HR comorbidities

1.03 [0.99;1.08]

0.17

0.94 [0.87;1.01]

0.1

1.11 [1.04;1.19]

0.001

  

No HR comorbidity

1.00 (ref)

 

1.00 (ref)

 

1.00 (ref)

 

1.00 (ref)

 

N = 1 HR comorbidity

1.01 [0.96;1.06]

0.67

0.93 [0.86;1.01]

0.08

1.08 [1.01;1.16]

0.024

0.97 [0.82;1.14]

0.6855

N ≥ 2 HR comorbidities

1.15 [1.05;1.26]

0.003

0.98 [0.85;1.13]

0.76

1.30 [1.14;1.47]

 < 0.0001

1.39 [0.97;2.00]

0.0766

Type of HR comorbidities

        

Solid tumor

0.96 [0.91;1.02]

0.16

0.90 [0.83;0.98]

0.0158

1.02 [0.95;1.10]

0.5511

0.90 [0.75;1.07]

0.2417

Hematological malignancy

1.22 [1.13;1.33]

 < 0.0001

1.06 [0.92;1.22]

0.4225

1.30 [1.17;1.45]

 < 0.0001

1.39 [1.08;1.79]

0.0116

Auto-immune disorders

1.01 [0.91;1.12]

0.87

0.89 [0.75;1.06]

0.1962

1.09 [0.95;1.26]

0.2381

1.10 [0.75;1.62]

0.6156

Primitive immune deficiency

1.28 [1.10;1.49]

0.001

1.15 [0.92;1.43]

0.2130

1.42 [1.13;1.77]

0.0022

1.71 [0.87;3.36]

0.1207

Organ transplant recipient

0.89 [0.75;1.05]

0.16

0.81 [0.67;0.99]

0.0391

1.20 [0.86;1.67]

0.2792

0.76 [0.19;3.11]

0.7055

HIV

1.72 [1.38;2.15]

 < 0.0001

1.73 [1.36;2.19]

 < 0.0001

1.77 [0.92;3.38]

0.0849

Asplenia—hyposplenia

1.21 [0.90;1.63]

0.204

1.40 [0.96;2.05]

0.0766

0.82 [0.47;1.42]

0.4733

2.69 [0.96;7.53]

0.0588

AR comorbidities

1.35 [1.25;1.46]

 < 0.0001

1.53 [1.39;1.69]

 < 0.0001

1.06 [0.92;1.21]

0.44

  

No AR comorbidity

1.00 (ref)

 

1.00 (ref)

 

1.00 (ref)

 

1.00 (ref)

 

N = 1 AR comorbidity

1.26 [1.15;1.38]

 < 0.0001

1.33 [1.19;1.49]

 < 0.0001

1.05 [0.90;1.22]

0.54

1.04 [0.72;1.52]

0.8294

N = 2 AR comorbidities

1.49 [1.36;1.62]

 < 0.0001

1.62 [1.44;1.81]

 < 0.0001

1.20 [1.04;1.38]

0.02

1.16 [0.81;1.67]

0.4162

N = 3 AR comorbidities

1.40 [1.28;1.53]

 < 0.0001

1.75 [1.55;1.98]

 < 0.0001

1.06 [0.92;1.23]

0.41

1.00 [0.69;1.44]

0.9949

N ≥ 4 AR comorbidities

1.19 [1.08;1.31]

 < 0.00001

1.60 [1.39;1.84]

 < 0.0001

0.87 [0.74;1.01]

0.07

0.92 [0.63;1.33]

0.6542

Type of AR comorbidities

        

Chronic cardiac diseases

1.03 [0.98;1.09]

0.26

1.07 [0.99;1.15]

0.0775

0.98 [0.90;1.06]

0.6197

1.09 [0.88;1.34]

0.4324

Malnutrition

0.98 [0.94;1.03]

0.54

1.29 [1.19;1.40]

 < .0001

0.82 [0.77;0.88]

 < 0.0001

1.03 [0.90;1.18]

0.6242

Chronic respiratory diseases

1.91 [1.83;2.00]

 < 0.0001

2.04 [1.90;2.20]

 < .0001

1.94 [1.82;2.06]

 < 0.0001

1.38 [1.19;1.60]

 < 0.0001

Diabetes mellitus

0.96 [0.91;1.02]

0.16

1.02 [0.93;1.11]

0.6883

0.96 [0.89;1.03]

0.2403

0.76 [0.63;0.93]

0.0079

Neurodegenerative diseases

0.52 [0.49;0.56]

 < 0.0001

0.56 [0.46;0.69]

 < 0.0001

0.48 [0.44;0.53]

 < 0.0001

0.68 [0.58;0.80]

 < 0.0001

Chronic kidney diseases

0.89 [0.83;0.94]

0.0001

0.88 [0.77;0.99]

0.0380

0.86 [0.79;0.93]

0.0003

1.00 [0.86;1.16]

0.9677

Stroke

0.64 [0.60;0.69]

 < 0.0001

0.70 [0.61;0.81]

 < 0.0001

0.60 [0.55;0.66]

 < 0.0001

0.74 [0.61;0.89]

0.0012

Chronic liver diseases

1.38 [1.27;1.50]

 < 0.0001

1.45 [1.30;1.62]

 < 0.0001

1.35 [1.18;1.55]

 < 0.0001

0.81 [0.47;1.38]

0.4372

  1. CAP community-acquired pneumonia, P-CAP pneumococcal community-acquired pneumonia, HR high-risk comorbidities (immunodepression, immunodeficiency, cancer), AR at risk comorbidities (comorbidities at risk of pneumococcal CAP in immunocompetent patients), y.o. year old, HIV human immunodeficiency virus, OR odds ratio, CI confidence interval